Related references
Note: Only part of the references are listed.Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions
F. Pignatti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Improving R&D productivity
Katarzyna Smietana et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Factors influencing quality decision-making: regulatory and pharmaceutical industry perspectives
Ronan Donelan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Insights Into the Decision Making of Advisory Groups to the Italian Medicines Agency
Michele Marangi et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2014)
Regulatory Review: How Do Agencies Ensure the Quality of Decision Making?
L. Liberti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
How FDA Advisory Committee Members Prepare and What Influences Them
Todd D. McIntyre et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2013)
Share Paper
